Back to Top Skip to main content Skip to sub-navigation

USU cohort study investigates COVID-19 impacts on DOD personnel

Image of Military health personnel wearing a mask and a face shield holding up a sign that has the number eighteen on it . Click to open a larger version of the image. Navy Hospital Corpsman 3rd Class Charles Cambern holds up a numbered sign as patients circle through to receive the COVID-19 vaccine at Walter Reed National Military Medical Center, in Bethesda, Maryland. WRNMMC is one of 10 DOD sites undertaking the EPICC study to better understand COVID-19 disease. (U.S. Navy photo by Ricardo Reyes)

Recommended Content:

MHS Toolkits and Branding Guidance | Immunizations | COVID-19 Vaccine Efforts | Coronavirus

The Uniformed Services University of the Health Sciences’ Infectious Disease Clinical Research Program is leading a multi-year study to identify risk factors for COVID-19 in the military population, understand the symptoms and disease course, and investigate clinical outcomes.

Epidemiology, Immunology, and Clinical Characteristics of Emerging Infectious Diseases with Pandemic Potential – or EPICC – study hopes to inform the Military Health System on ways to improve the patient care and treatment, infection, and disease prevention of those with COVID-19. USU is working in partnership with a network of military commands, treatment facilities, and laboratories across the country for EPICC.

Findings from the study “will support further understanding of the impact of SARS-COV-2 infection on active-duty readiness, acute and chronic clinical outcomes, the effectiveness of new treatments and vaccines, and address questions related to the emergence of new variants and their clinical impact,” said Dr. Brian Agan, deputy science director of IDCRP and principal investigator of the study.

The study is also evaluating how long the immune response to the COVID-19 vaccines lasts, breakthrough infections – which happen when a vaccinated individual becomes sick from the same illness the vaccination is designed to prevent – and how they behave over time, and estimating vaccine effectiveness, said Agan, who is also an employee of the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

Department of Defense service members and MHS beneficiaries of any age with COVID-19-like illness who are admitted to the hospital or treated as outpatients at an EPICC site can join. Likewise, those 18 years or older who have been tested for COVID-19, whether they tested positive or negative, can participate in the online portion of the study, which includes self-collected blood specimens for selected participants.

The protocol was recently updated to also enroll COVID-19 vaccine recipients and will initiate recruitment upon approval, said Navy Capt. (Dr.) Timothy Burgess, program director of IDCRP, who oversees the study. Eligible beneficiaries who are interested in participating in EPICC can submit an online screening form to join.

“In addition, asymptomatic individuals with a high risk of exposure are also eligible for enrollment in EPICC, which includes health care workers and close contacts of cases,” said Burgess. “Particularly, health care workers who have received a COVID-19 vaccination will be an important population for studies to examine vaccine effectiveness and outcomes.”

Data from inpatient, outpatient, and online participants, including their clinical characteristics, comorbidities, the clinical course of their illness, treatment, immunology, and outcomes, is being collected for the study.

“Questionnaires are provided to enrollees to collect information on demographics, symptoms at initial presentation and chronic or persisting symptoms during follow-up, exposure history, and lifestyle factors,” said Burgess. “Clinical and research specimens collected from enrollees are examined using molecular, serological, and other immune assays in collaboration USU and non-USU partner laboratories.”

Initiated in March 2020, EPICC is expected to continue enrolling participants at least through March 2022, or for as long as needed to fill in the knowledge gaps related to this disease, explained Agan.

“Once enrolled, participants are actively followed for one year to fully capture specimens and data including chronic outcomes and sequelae and will be followed for up to four additional years through electronic medical record review,” Agan said.

EPICC is being conducted at 10 military medical treatment facilities throughout the United States:

  • Brooke Army Medical Center in Fort Sam Houston, Texas
  • Carl R. Darnall Army Medical Center in Fort Hood, Texas
  • Fort Belvoir Community Hospital in Fort Belvoir, Virginia
  • Joint Base Lewis-McChord, Washington
  • Naval Medical Center Portsmouth in Portsmouth, Virginia
  • Naval Medical Center San Diego in San Diego, California
  • Tripler Army Medical Center in Honolulu, Hawaii
  • William Beaumont Army Medical Center in El Paso, Texas
  • Womack Army Medical Center in Fort Bragg, North Carolina
  • Walter Reed National Military Medical Center in Bethesda, Maryland

Military health personnel wearing a face mask and shield speaking to a man who is wearing a face mask
Navy Hospital Corpsman 3rd Class Michael A. Torrent conducts a pre-screening questionnaire prior to administering the COVID-19 vaccine as part of Operation Warp Speed at Walter Reed National Military Medical Center. (U.S. Navy photo by Ricardo Reyes)

By the first week of February, more than 1,600 active-duty service members and MHS beneficiaries had enrolled in EPICC, the majority of whom are being treated as outpatients, said Agan. Approximately half of the subjects with confirmed SARS-CoV-2 diagnoses included in EPICC are active-duty service members.

Some interesting observations the researchers found thus far are that the characteristics of hospitalized COVID-19 patients compared to those treated as outpatients has shown a higher proportion of comorbidities, with hypertension, diabetes, and obesity being most prevalent, said Agan. In fact, their findings have begun to identify why obesity is a risk factor for more severe disease.

They were also able to garner valuable insight into the risk of reinfection from a military health care worker enrolled in the study who was reinfected with a symptomatic case of COVID-19. 

“A median time to recovery has been identified as 14 days, with nine lost duty days among active-duty service members,” said Agan. “These findings not only support operational planning, but also provide an important baseline to evaluate the effectiveness of vaccines as uptake widens across the DOD.”

They also found that the antibody levels that cause immunity remain in individuals for more than six months post-infection and that there were no “seroreversions” after six months post-infection. Seroreversion is the loss of serologic reactivity, or the presence of a particular antigen in the blood, whether spontaneous or in response to therapy. 

“With ongoing concerns about the magnitude and duration of immunity post-infection, our findings were both surprising and a relief,” said Burgess.

The researchers hope the information on the effectiveness and safety of the vaccines will alleviate concerns and encourage individuals to be vaccinated. And as the vaccine rollout expands to more recipients, the study will benefit from recruiting participants among the growing population of vaccinated recipients.

“This will enhance our ability to evaluate vaccine effectiveness in the population and if other reports showing high levels of protection are confirmed, our work may help boost confidence among those who are less certain,” said Burgess. “We are excited about the ability of the EPICC study to answer key questions for patients, health care providers, and leadership to guide decisions as we steer through the coming months of this unprecedented and historic pandemic.

You also may be interested in...

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

DHA’s IT innovation continues during COVID-19 pandemic

Article
12/31/2020
Image of three military personnel, wearing masks, in front of a computer screen. Click to open a larger version of the image.

IT innovations keep pace despite COVID-19 road blocks.

Recommended Content:

Coronavirus | Research and Innovation | Technology | Electronic Health Record: MHS GENESIS | Coronavirus and the COVID-19 Vaccine

MTFs respond to COVID-19 with increased telehealth, drive-thrus

Article
12/29/2020
Military physician sitting at desk, talking to patient on his computer

COVID MTF innovations include more virtual health options and drive thrus.

Recommended Content:

Coronavirus | Technology | Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine

HHS and DOD statements on FDA authorization of Moderna vaccine

Article
12/28/2020
Image with documents and vaccine products laying on table

Operation Warp Speed has allocated more than 5.9 million doses of the vaccine for jurisdictions to receive in the coming week.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Vaccine Trials | Coronavirus and the COVID-19 Vaccine

MHS Minute: December 2020

Video
12/28/2020
MHS Minute: December 2020

See how MHS is leading a phased approach to offer 11.1 million Department of Defense personnel the first COVID-19 vaccines. To learn more about the safety and efficacy behind COVID-19 vaccines, go to: https://www.health.mil/Military-Health-Topics/Combat-Support/Public-Health/Coronavirus/COVID-19-Vaccine-Efforts.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | MHS Toolkits and Branding Guidance

Protecting the Force: How the MHS helped sustain readiness in the face of COVID

Article
12/23/2020
Hospital personnel treating a patient on a stretcher

The Military Health System is reviewing how it kept warfighters mission-ready and units online in 2020 during the ongoing pandemic.

Recommended Content:

Combat Support | Coronavirus | Coronavirus and the COVID-19 Vaccine | Readiness Capabilities

MHS Team Resiliency Awards recognize medical response to COVID-19

Article
12/22/2020
Sailors wearing masks, leaning on a table and writing on sheets of paper

Outstanding efforts recognized during Resiliency Awards

Recommended Content:

Coronavirus | Research and Innovation | Patient Safety | Patient Safety Awards Program | Ready and Resilient Award

AFHSD’s GEIS collect data worldwide to support force protection

Article
12/22/2020
Medical personnel scanning forehead of soldier with thermometer

AFHSD/GEIS continue work with partners across the globe in their efforts to combat COVID-19 and protect military readiness.

Recommended Content:

Health Readiness | Public Health | Coronavirus | Environmental Exposures | Global Health Engagement | Armed Forces Health Surveillance Division | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

Military Health System encourages influenza vaccination for 2020

Article
12/21/2020
Military personnel giving patient a flu vaccine in her left arm

The CDC notes that COVID-19 seems to spread more easily than flu and causes more serious illnesses in some people.

Recommended Content:

Influenza, Northern Hemisphere | Influenza, Southern Hemisphere | Influenza Summary and Reports | Coronavirus | Public Health | Seasonal Influenza Vaccine Toolkit

MHS COVID Response

Video
12/21/2020
MHS COVID Response

The men and women of the Military Health System spent 2020 working to protect beneficiaries' health during the coronavirus pandemic. Here are just a few of our accomplishments.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

Frontline Indiana Guardsmen receive COVID-19 vaccination

Article
12/18/2020
Soldier getting a vaccine in his left arm

These Guardsmen are trained medics who also took Centers for Disease Control and Prevention courses specific to the coronavirus.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | MHS Toolkits and Branding Guidance | Coronavirus and the COVID-19 Vaccine

Defense Health Agency Director: Vaccine rollout safe and effective

Article
12/18/2020
Image of military personnel giving a vaccine to a soldier in her right arm. Click to open a larger version of the image.

“In the coming months as the vaccine becomes more widely available, we strongly encourage everyone to get this vaccine,” Place stressed.

Recommended Content:

MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

CDC provides COVID-19 vaccine best practices for healthcare providers

Article
12/17/2020
Medical personnel filling a syringe from a vaccine bottle

[T]he Defense Health Agency’s Immunization Healthcare Division (IHD) is working in collaboration with the CDC to offer the training to the Military Health System’s health care providers.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | MHS Toolkits and Branding Guidance | Coronavirus and the COVID-19 Vaccine

Top five digital health trends for military medical providers in 2021

Article
12/17/2020
Image of Dr. Pincus with text "Top Five Digital Health Trends for Military Medical Providers in 2021"

One way the MHS will provide...improved care is through DoD’s new electronic health record MHS GENESIS, which will continue its rollout through 2023.

Recommended Content:

Coronavirus | Electronic Health Record: MHS GENESIS
<< < ... 16 17 18 19 20  ... > >> 
Showing results 286 - 300 Page 20 of 39

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.